Emergent Derivative Suit Stayed In Del. Pending Md. Action
By Jeff Montgomery ( March 29, 2022, 6:16 PM EDT) -- Potential conflicts with a pending federal stockholder class lawsuit have sidelined a Delaware Chancery Court derivative action seeking hundreds of millions in damages on behalf of Emergent Biosolutions Inc. for director and officer failures during a COVID-19 vaccine production drive....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.